The 2024 mid-term review will serve to assess progress made in the implementation of all international drug policy commitments as set forth in the 2019 Ministerial Declaration. Preceding the 2024 mid-term review will be a comprehensive stock-taking of all 11 challenges related to the world drug problem identified in the Ministerial Declaration, which will take place during the thematic discussions to be held 23-25 October and 4-6 December 2023. This comprehensive stock-taking complements the thematic discussions held by the Commission since 2019. An end-of-cycle review of the implementation of all international drug policy commitments is planned for 2029.
The mid-term review will be held in March 2024. Through resolution 66/1, the Commission decided how the 2024 mid-term review would take place.
